Orca Bio’s Orca-Q receives US FDA’s RMAT designation for treatment of high-risk hematologic malignancies: Menlo Park, California Orca ...

New study highlights societal optimism toward breakthrough science, and rising anxiety about how fast the world is changing: Berlin Thursday, April 30, 202 ...

Vensica Medical receives US FDA IND clearance to begin phase 2 study of ViXe; a needle-free Xeomin delivery system for overactive bladder: New York Thursday, April 30, 2026, 17:00 ...

National IPR conference at MIPS bridges gap between pharma research and industrial innovation: Our Bureau, Chennai Thursday, ...

US FDA grants priority review to BeOne Medicines’ sBLA for Tevimbra in first-line HER2+ GEA: San Carlos, California Thursday, April 30, 2026, 16:00 Hrs [IST] BeOne Medicines Ltd ...

NHPC organises Heart Health Talk and Awareness Camp in association with Heartnet India: Our Bureau, Mumbai Thursday, April 30 ...

Lilly supports Haryana State-FDA action on counterfeits, reiterates sourcing via authorised channels on valid prescription: ...

Pfizer announces positive results from phase 3 MagnetisMM-5 study of Elrexfio as monotherapy in adults with relapsed or refractory multiple myeloma: New York Thursday, April 30, 2 ...

Abbott receives US FDA clearance and CE Mark for next-generation Ultreon 3.0 AI-powered coronary imaging platform: Abbott Park, Illinois Thursday, April 30, 2026, 14:00 Hrs [IST] ...

Parexel adds new technology capabilities in patient safety solutions with acquisition of Vitrana: Our Bureau, Bengaluru Thursday, April 30, 2026, 13:45 Hrs [IST] Parexel, a leadin ...

Syngene PAT before exceptional items slips in Q3 by 16%, revenue up 2% to Rs. 1,037 crore: Our Bureau, Bengaluru Thursday, April 30, 2026, 13:30 Hrs [IST] Syngene International, I ...

Thermo Fisher opens bioprocess design centre in US to support customers developing and scaling biologics: Waltham, Massachusetts Thursday, April 30, 2026, 13:00 Hrs [IST] Thermo F ...